as informed in thebody
HIV Advocates Face Challenges New and Old After Stunning U.S. Elections
HIV Advocates Face Challenges New and Old After Stunning U.S. Elections
It is not an overstatement to say that the nation Americans woke up to yesterday is charted on a fundamentally different course than the day before.The differences in both temperament and in policy between the now President-elect Donald Trump and Hillary Clinton could hardly have been starker.For people living with or affected by HIV, the choice was between a woman who had been working to end the HIV epidemic for more than 2 decades as a First Lady, Senator, and Secretary of State and a man whose campaign didn't have an HIV/AIDS policy.
coupled with empr
New Approach to HIV May One Day Allow Patients to Stop ART
New Approach to HIV May One Day Allow Patients to Stop ART
New Approach to HIV May One Day Allow Patients to Stop ARTThis article originally appeared here.Two trials suggest approach might make it possible for patients to discontinue antiretroviral medsHealthDay News — Antibodies may keep the HIV virus in check and one day allow patients to stop taking antiretroviral drugs, according to research published online November 9 in the New England Journal of Medicine.For one study (National Institutes of Health), patients were given infusions of VRC01 before they stopped antiretroviral therapy.
not to mention huffingtonpost
A Promising Study Reveals New Hope For An HIV Cure
A Promising Study Reveals New Hope For An HIV Cure
A new experimental HIV vaccine, when combined with a compound that stimulates a person's immune system, demonstrated potential for a path to curing HIV.The small study, involving rhesus monkeys who had the monkey equivalent of HIV, revealed that this novel combination was effective at suppressing the virus to undetectable levels in a few of the subjects, without the need for antiretroviral treatments.If the combination of the HIV vaccine and immune system compound is shown to be effective in people, it could mean one step toward a cure for HIV, said lead investigator Dan Barouch, director for the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center and Harvard Medical School.
No comments:
Post a Comment